RYGB outperforms drugs, gastrectomy in lowering A1C

02/26/2013 | MedPage Today (free registration)

Roux-en-Y gastric-bypass surgery fared better than sleeve gastrectomy and optimal medical therapy in reducing A1C levels and boosting insulin sensitivity and beta-cell function in patients with diabetes, according to a study in Diabetes Care. "Gastric bypass essentially was like CPR to a failing pancreas. It was able to restore its function, and this led to durable blood sugar control for these patients," said researcher Dr. Sangeeta R. Kashyap.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA